Ratings by Wedbush
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/2/2026 | David Nierengarten | Tscan Therapeutics Inc | TCRX | Downgrade | Neutral (Outperform) |
N/A (N/A) |
0.67 (0.39) |
-41.79% | Details |
| 8/24/2026 | Seth Basham | Best Buy | BBY | Maintain | Neutral (N/A) |
85.00 (75.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 8,825 more... | |||||||||
